Comparison Chart Oragenics, Inc.

Stocks

OGEN

US6840236094

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 16:00:00 2026-07-24 EDT			5-day change	1st Jan Change
0.5110 ^USD	+1.17%		-7.02%	-34.75%

07-07	Oragenics Achieves Full Activation of Australian Phase IIa Trial Network for ONP-002 and Advances U.S. Regulatory Pathway	CI
07-07	Oragenics Says All Three Australian Concussion Trial Sites Enrolling Patients	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ORAGENICS, INC.	Bio Therapeutic Drugs	+1.17%	-7.02%	-34.75%	-63.24%	-99.96%	2.31M